(WITHDRAWN)Prot#E5501-G000-202: A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy, Safety, and Population Pharmacokinetics of One-Daily Oral E5501 Tablets Used Up to 7 Days in Subjects wit